Preconditioning by angiotensin II: a tale of more than two kinases.
Dawn
Buddhadeb
B
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D019157:Ischemic Preconditioning, Myocardial; D020935:MAP Kinase Signaling System / Q000187:drug effects*; D008297:Male; D009097:Multienzyme Complexes / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000201:enzymology* / Q000473:pathology; D009206:Myocardium / Q000201:enzymology* / Q000473:pathology; D032383:Myocytes, Cardiac / Q000201:enzymology / Q000473:pathology; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010477:Perfusion; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism
D009097:Multienzyme Complexes; D017382:Reactive Oxygen Species; D000804:Angiotensin II; C023107:NADH oxidase; D009247:NADH, NADPH Oxidoreductases; D011494:Protein Kinases